FULLER & THALER ASSET MANAGEMENT, INC.
Position in VNDA — Vanda Pharmaceuticals Inc.
CIK 1082327
SAN MATEO, CA
Position in VNDA
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$302,083
-$41,689 QoQ
Shares Held
49,360
-0.8% QoQ
Ownership
0.082%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#74
of 172 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 85%
Shared 0%
None 15%
Common Shares in VNDA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026FULLER & THALER ASSET MANAGEMENT, INC. holds $1,207,612,518 across 7 Biotechnology names. VNDA ranks #7 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
8,929,389 | $485,848,055 | |
| 2 | JAZZ |
Jazz Pharmaceuticals plc
|
1,638,544 | $394,839,947 | |
| 3 | HALO |
Halozyme Therapeutics, Inc.
|
1,491,004 | $116,700,883 | |
| 4 | PTCT |
Ptc Therapeutics, Inc.
|
1,156,819 | $94,361,725 | |
| 5 | CORT |
Corcept Therapeutics Inc
|
710,106 | $61,743,716 | |
| 6 | CELC |
Celcuity Inc.
|
514,396 | $53,816,109 | |
| 7 | VNDA |
Vanda Pharmaceuticals Inc.
This page
|
49,360 | $302,083 |
All Filings in VNDA
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $302,083 | 49,360 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $343,772 | 49,750 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $438,795 | 49,750 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $248,252 | 49,750 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $234,820 | 49,750 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $279,622 | 60,920 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $287,974 | 60,120 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $281,962 | 60,120 | Shares | Sole | 2024-11-13 | |
| No filing history on record for this holder in this stock. | ||||||